Global Bioenergies

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Real-time Euronext Paris Other stock markets 08:07:19 2024-06-19 am EDT			5-day change	1st Jan Change
1.65 ^EUR	+0.61%		-9.74%	-18.32%

May. 29	Global Bioenergies Announces Completion of the Basic Engineering Phase and Success of the Related Test Campaign	CI
Apr. 09	Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	MT

Global Bioenergies SA announced that it has received funding from INOCAP Gestion, Amiral Gestion SA

January 30, 2016

Global Bioenergies SA (ENXTPA:ALGBE) announced that it has received a round of funding from new investor INOCAP Gestion and Amiral Gestion SA on January 31, 2016.

Latest news about Global Bioenergies

Global Bioenergies Announces Completion of the Basic Engineering Phase and Success of the Related Test Campaign	May. 29	CI
Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	Apr. 09	MT
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Global Bioenergies Partners with Shell on More Focused Development of Low-carbon Road Fuels	Jan. 18	MT
Global Bioenergies SA Announces Board Changes	Jan. 17	CI
Global Bioenergies: financial visibility extended	Nov. 16	CF
Global Bioenergies Hires Chief Business Officer	23-10-19	MT
Global Bioenergies Announces the Appointment of Martin Stephan as Chief Business Officer	23-10-19	CI
Global Bioenergies Secures EUR16 Million Government Funding for Biosourced Isobutene Plant	23-10-04	MT
Global Bioenergies: disappointment after half-year results	23-09-20	CF
Global Bioenergies SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-19	CI
Global Bioenergies Launches Isonaturane® 16, Its Second Cosmetic Ingredient	23-03-30	CI
Global markets live: Blackberry, Meta Platforms, Rivian, GM...	23-03-07
Global Bioenergies: capital increase, share price falls	23-03-07	CF
Global markets live: Airbus, Walmart, Meta, Home Depot...	23-02-21
Global Bioenergies: research contract extended with Shell	23-02-21	CF
Global Bioenergies, Shell Extend Renewable Road Fuels R&D Deal	23-02-21	MT
Global Bioenergies Successfully Hits Milestone in Shell Collaboration and Signs Follow-On Agreement	23-02-21	CI
Global Bioenergies: significant sales in 2022	23-02-14	CF
Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-14	CI
Global Bioenergies Scales Up Production at Pomacle Commercial Unit	22-12-06	MT
Global Bioenergies Announces the Successful Scale-Up of Production At Its Pomacle Commercial Unit	22-12-06	CI
Shell Teams Up With Global Bioenergies to Develop Low-Carbon Road Fuels	22-11-14	MT
Global Bioenergies Agrees Collaboration with Shell in the Development of Low Carbon Road Fuels	22-11-14	CI
Global Bioenergies Renews Equity Line With Kepler Cheuvreux	22-11-11	MT

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-09-17 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Global Bioenergies

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.64 EUR

Average target price

2.6 EUR

Spread / Average Target

+58.54%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GLOBAL BIOENERGIES	-18.32%	31.93M
THERMO FISHER SCIENTIFIC	+7.23%	217B
DANAHER CORPORATION	+11.31%	191B
INTUITIVE SURGICAL, INC.	+28.94%	154B
BOSTON SCIENTIFIC CORPORATION	+32.00%	112B
SIEMENS HEALTHINEERS AG	-0.68%	62.84B
EDWARDS LIFESCIENCES CORPORATION	+16.09%	53.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.80%	48.83B
AGILENT TECHNOLOGIES, INC.	-2.97%	39.36B
GE HEALTHCARE TECHNOLOGIES INC.	+1.23%	35.73B

Other Advanced Medical Equipment & Technology